A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma

Name: A Study to Assess the Efficacy of 3 Months of Latanoprost Treatment in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-angle Glaucoma
License: Public Domain

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

glaucoma

glaucoma, open-angle, ocular hypertension

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 125967
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.